A POINT MUTATION AT CODON-13 OF THE N-RAS ONCOGENE IN MYELODYSPLASTIC SYNDROME

被引：227
|
作者：
HIRAI, H
KOBAYASHI, Y
MANO, H
HAGIWARA, K
MARU, Y
OMINE, M
MIZOGUCHI, H
NISHIDA, J
TAKAKU, F
机构：
[1] GUNMA UNIV,SCH MED,DEPT INTERNAL MED 3,MAEBASHI,GUNMA 371,JAPAN
[2] TOKYO WOMENS MED COLL,DEPT MED,DIV MED 1,SHINJUKU KU,TOKYO 162,JAPAN
来源：
NATURE | 1987年 / 327卷 / 6121期
关键词：
D O I：
10.1038/327430a0
中图分类号：
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号：
07 ; 0710 ; 09 ;
摘要：
引用
收藏
页码：430 / 432
页数：3
相关论文
共 50 条
  • [41] MUTATIONAL ACTIVATION OF THE N-RAS ONCOGENE ASSESSED IN PRIMARY CLONOGENIC CULTURE OF ACUTE MYELOID-LEUKEMIA (AML) - IMPLICATIONS FOR THE ROLE OF N-RAS MUTATION IN AML PATHOGENESIS
    BASHEY, A
    GILL, R
    LEVI, S
    FARR, CJ
    CLUTTERBUCK, R
    MILLAR, JL
    PRAGNELL, IB
    MARSHALL, CJ
    BLOOD, 1992, 79 (04) : 981 - 989
  • [42] SILENT MUTATION AT CODON-15 INTERFERES WITH THE DETECTION OF A MUTATED N-RAS CODON-12 ALLELE BY OLIGONUCLEOTIDE HYBRIDIZATION
    JANSSEN, JWG
    BARTRAM, CR
    LEUKEMIA, 1989, 3 (03) : 235 - 235
  • [43] N-RAS 61 ONCOGENE MUTATIONS IN HURTHLE CELL TUMORS
    SCHARK, C
    FULTON, N
    JACOBY, RF
    WESTBROOK, CA
    STRAUS, FH
    KAPLAN, EL
    SURGERY, 1990, 108 (06) : 994 - 1000
  • [44] LOSS OF RAS ONCOGENE MUTATION IN A MYELODYSPLASTIC SYNDROME AFTER LOW-DOSE CYTARABINE THERAPY
    LAYTON, DM
    MUFTI, GJ
    LYONS, J
    JANSSEN, JWG
    BARTRAM, CR
    NEW ENGLAND JOURNAL OF MEDICINE, 1988, 318 (22): : 1468 - 1469
  • [45] MALIGNANT TRANSFORMATION OF HUMAN FIBROBLASTS BY A TRANSFECTED N-RAS ONCOGENE
    WILSON, DM
    YANG, D
    DILLBERGER, JE
    DIETRICH, SE
    MAHER, VM
    MCCORMICK, JJ
    CANCER RESEARCH, 1990, 50 (17) : 5587 - 5593
  • [46] MUTATION ANALYSIS OF THE N-RAS PROTO-ONCOGENE IN ACTIVE AND REMISSION PHASE OF HUMAN ACUTE LEUKEMIAS
    SENN, HP
    TRANTHANG, C
    WODNARFILIPOWICZ, A
    JIRICNY, J
    FOPP, M
    GRATWOHL, A
    SIGNER, E
    WEBER, W
    MORONI, C
    INTERNATIONAL JOURNAL OF CANCER, 1988, 41 (01) : 59 - 64
  • [47] THE MUTATION OF N-RAS ONCOGENE DOES NOT INVOLVE MYELOID AND ERYTHROID LINEAGES IN A CASE OF MULTIPLE-MYELOMA
    CORRADINI, P
    FERRERO, D
    VOENA, C
    LADETTO, M
    BOCCADORO, M
    PILERI, A
    BRITISH JOURNAL OF HAEMATOLOGY, 1993, 83 (04) : 672 - 673
  • [48] ONCOGENICITY OF HUMAN N-RAS ONCOGENE AND PROTO-ONCOGENE INTRODUCED INTO RETROVIRAL VECTORS
    SOUYRI, M
    VIGON, I
    CHARON, M
    TAMBOURIN, P
    JOURNAL OF VIROLOGY, 1989, 63 (09) : 3944 - 3953
  • [49] N-RAS MUTATIONS ARE ASSOCIATED WITH POOR-PROGNOSIS AND INCREASED RISK OF LEUKEMIA IN MYELODYSPLASTIC SYNDROME
    PAQUETTE, RL
    LANDAW, EM
    PIERRE, RV
    KAHAN, J
    LUBBERT, M
    LAZCANO, O
    ISAAC, G
    MCCORMICK, F
    KOEFFLER, HP
    BLOOD, 1993, 82 (02) : 590 - 599
  • [50] Case Report: Mucinous Cystadenocarcinoma of the Spleen Presenting a Point Mutation of the Kirsten-ras Oncogene at Codon 12
    Masahiko Hirota
    Naoko Hayashi
    Tsutomu Tomioka
    Seiichi Murakami
    Hisami Ohshima
    Katsumi Yamasaki
    Junji Miyamoto
    Saburo Tamiya
    Michio Ogawa
    Digestive Diseases and Sciences, 1999, 44 : 768 - 774
12345